Patent References[[4 -[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]-methyl]-1H- imidazoles and 1H-1,2,4-triazoles having antimicrobial properties 2-Azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof, agents containing same, and the use thereof 1-[1-aryl-1-hydroxy-2-azolyl-ethyl]-1-aryl-cyclopropane derivatives, and their fungicidal use thereof Patent #: 4870088 InventorsApplicationNo. 714820 filed on 06/13/1991US Classes:514/32, Oxygen of the saccharide radical bonded to a nonsaccharide hetero ring by acyclic carbon bonding514/247, Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.)514/252.11, Plural 1,4-diazine rings attached directly or indirectly to each other by nonionic bonding514/253.01, The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms514/253.06, Quinolines (including hydrogenated)514/254.01, The additional hetero ring is five-membered having ring nitrogen514/254.02, The additional five-membered hetero ring also has chalcogen as a ring member514/254.05, Plural nitrogens in the additional five-membered hetero ring514/255.01, Nitrogen or -C(=X)-, wherein X is chalcogen, bonded directly to the piperazine ring514/255.02, Chalcogen bonded directly to a piperazine ring carbon514/277, Hetero ring is six-membered consisting of one nitrogen and five carbon atoms514/408, The five-membered hetero ring consists of one nitrogen and four carbons514/410, Polycyclo ring system having the five-membered hetero ring as one of the cyclos514/422, Additional hetero ring514/426Nitrogen bonded directly to the five-membered hetero ring by nonionic bondingExaminersPrimary: Nutter, Nathan M.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/395A61K 031/415 A61K 031/425 A61K 031/44 AbstractCompounds which inhibit Candida acid protease are disclosed which have the formula: ##STR1## wherein R1 is loweralkyl, loweralkenyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, cycloalkenylalkyl, arylalkyl or (heterocyclic)alkyl;R2 is loweralkyl, cycloalkylalkyl or arylalkyl;R3 is --OH or --NH2 ;R4 is(a) --CH(OH)--R5 wherein R5 is loweralkyl, cycloalkyl or cycloalkylalkyl or(b) --CH2 CH(R6)C(O)NHR7 wherein R6 is loweralkyl and R7 is loweralkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, hydroxyalkyl, alkoxyalkyl, thioalkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, cyanoalkyl or (heterocyclic)alkyl; andA is ##STR2## wherein R8 is arylalkyl, B is --C(O) or --S(O)2 -- and R9 is aryl, arylalkyl, heterocyclic or (heterocyclic)alkyl; or ##STR3## wherein R10 is arylalkyl and R11 is (a) --C(O)R12 wherein R12 is alkoxy, arylalkoxy, aryl, arylalkyl, heterocyclic or (heterocyclic)alkyl or (b) --S(O)2 --R13 wherein R13 is aryl, arylalkyl, heterocyclic or (heterocyclic)alkyl; or a pharmaceutically acceptable salt, ester or prodrug thereof.Other References
Field of SearchOxygen of the saccharide radical bonded to a nonsaccharide hetero ring by acyclic carbon bondingHetero ring is six-membered consisting of one nitrogen and five carbon atoms The five-membered hetero ring consists of one nitrogen and four carbons Polycyclo ring system having the five-membered hetero ring as one of the cyclos Additional hetero ring Nitrogen bonded directly to the five-membered hetero ring by nonionic bonding Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) | |